SMS Pharmaceuticals Limited

Equities

SMSPHARMA

INE812G01025

Pharmaceuticals

Delayed NSE India S.E. 02:05:04 2024-07-09 am EDT 5-day change 1st Jan Change
248 INR -1.82% Intraday chart for SMS Pharmaceuticals Limited +1.21% +108.96%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Chart SMS Pharmaceuticals Limited
More charts
SMS Pharmaceuticals Limited is an India-based pharmaceutical manufacturing company. The Company is engaged in the business of manufacturing of active pharma ingredients and their intermediates. Its product categories include anti-ulcer, anti-inflammatory, anti-migraine, ant-diabetic, anti-coagulant, anti-viral, anti-retroviral, anti-psychotic, and others. The Company products include ranitidine, famotidine, pantoprazole sodium, itraconazole, lanoconazole, luliconazole, ibuprofen, Dex ibuprofen, fenoprofen calcium, sumatriptan, almotriptan, zolmitriptan, rizatriptan, Ele triptan, vildagliptin, sitagliptin, rosiglitazone, empagliflozin, dapagliflozin, tenofovir, dolutegravir, raltegravir, lamivudine, efavirenz, apixaban, rivaroxaban, levetiracetam, perampanel, lamotrigine, penciclovir, valaciclovir, and others. The Company has manufacturing facilities at Bachupally, Hyderabad, Telangana and also at Kandivalasa Village, Poosapatirega Mandal, Vijayanagaram District, Andhra Pradesh.
More about the company
  1. Stock Market
  2. Equities
  3. SMSPHARMA Stock
  4. News SMS Pharmaceuticals Limited
  5. SMS Pharmaceuticals to Raise Up to INR1.14 Billion from Convertible Warrants